Skip to content
Screener

Archer Aviation ACHR Research and development warrant expense

Research and development warrant expense at other companies

Beam Therapeutics logo
Beam TherapeuticsBEAM
$30.08M-12.6%
Solid Biosciences Inc. logo
Solid Biosciences Inc.SLDB
$9.06M+33.9%
Disc Medicine logo
Disc MedicineIRON
$11.31M+67.6%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
$90.53M+96.5%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$104.8M-7.5%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$23.42M+66.4%

Segments

By segment

See full
Reportable Segment$0-100%

Other financials

Income statement

See full
Revenue$1.6M
Gross profit$300.0K
Operating income-$254.6M-76.8%
Net income-$217.7M-133%
EPS (diluted)-$0.28-64.7%

Balance sheet

See full
Cash & equivalents$958.4M-7.6%
Total debt$121.8M+55.6%
Total equity$2.1B+106%
Total assets$2.3B+91.2%

Cash flow

See full
Operating cash flow-$149.1M-57.6%
CapEx$32.6M+226%
Free cash flow-$181.7M-73.7%

Valuation

See full
Market cap$3.99B-26.2%
Enterprise value$3.15B-16.3%
P/S2,493.6×

Profitability

See full
Gross margin18.8%
Operating margin-52,493.8%
Net margin-46,406.3%
FCF margin-36,800%

Returns & leverage

See full
Return on equity-48%-12.4pp
Debt / equity0.1×0.0×
Current ratio18.1×+2.3×

Where this comes from

Reported directly by Archer Aviation in its filing.

Tagged under the XBRL concept achr:ResearchAndDevelopmentWarrantExpense.

The source filing: Archer Aviation’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 5:01 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001824502-26-000038
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Revenue$1.6
Operating expenses
Depreciation and amortization expense7.84.1
Research and development warrant expense0.8
Stock-based compensation expense70.430.1
General and administrative warrant expense1.1
Other cost of revenue0.9
Other research and development expense133.388.2

Item 1. Financial Statementsii

FAQ

What is Archer Aviation's research and development warrant expense?
Archer Aviation (ACHR) reported research and development warrant expense of $0 in Q1 2026.
How has Archer Aviation's research and development warrant expense changed year-over-year?
Archer Aviation's research and development warrant expense decreased by 100.0% year-over-year, from $800K to $0.
What is the long-term trend for Archer Aviation's research and development warrant expense?
Over 3 years (2022 to 2025), Archer Aviation's research and development warrant expense has grown at a 4.4% compound annual growth rate (CAGR), from $2.9M to $3.3M.
What does research and development warrant expense mean?
Captures the portion of warrant-related expenses specifically allocated to research and development activities, often involving equity-based compensation granted to partners or vendors. This highlights the non-cash cost of incentivizing innovation through equity-linked instruments.

Ask your AI about Archer Aviation's research and development warrant expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude